US Patent 11976134 MUC16 specific chimeric antigen receptors and uses thereof
Patent 11976134 was granted and assigned to Precigen on May, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+33 properties)
Article (+280 characters)
US Patent 11976134 MUC16 specific chimeric antigen receptors and uses thereof
Article
Patent abstract
Provided herein are chimeric antigen receptors (CARs) for cancer therapy, and more particularly, CARs containing a scFv from an anti-MUC16 monoclonal antibody. Provided are immune effector cells containing such CARs, and methods of treating proliferative disorders.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Helen Sabzevari0
Rutul Shah0
Date of Patent
May 7, 2024
0Patent Application Number
176500250
Date Filed
February 4, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11976134 MUC16 specific chimeric antigen receptors and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.